Why a Fair Price Wasn’t Enough: What Coster v. UIP Means for Valuation in Deadlocked Companies

Chris Walton Written by Chris Walton, JD
Chris Walton
Chris Walton, JD
President & CEO
Chris Walton, JD, is President and CEO and co-founded Eton Venture Services in 2010 to provide mission-critical valuations to private companies. He leads a team that collaborates closely with each client’s leadership, board of directors, legal counsel, and independent auditors to develop detailed financial models and create accurate, audit-ready valuations.

Chris has led thousands of valuations, including for equity securities, intangible assets, financial instruments, investment valuations, business valuations for tax compliance and financial reporting compliance, as well as fairness and solvency opinions.

Read my full bio here.

If you advise closely held companies, you’ve dealt with a deadlock. Two equal shareholders who can’t agree on directors, can’t agree on strategy, and are slowly grinding the business to a halt while their lawyers file motions. The usual playbook is familiar: one side files for a custodian, the other side tries to resolve the impasse before the court appoints one.

In Coster v. UIP Companies, Inc., 2022 WL 1299127 (Del Ch. May 2, 2022), the board tried a different move — it sold stock to a long-time employee to break the 50/50 deadlock. The price was based on an independent valuation. The Chancery Court found the transaction entirely fair. And the Delaware Supreme Court reversed anyway, twice sending the case back for further analysis. The reason is the part that matters for practitioners: a fair price does not, by itself, authorize a board to dilute a shareholder’s voting rights. Entire fairness is necessary but not sufficient when the franchise is at stake. That distinction has real consequences for how valuations are used — and misused — in deadlock and squeeze-out situations.

What Actually Happened

UIP Companies was a multi-entity real estate investment operation in Washington, D.C. Marion Coster and Steven Schwat each owned 50% of the company. Their relationship had deteriorated to the point where they couldn’t elect a board of directors. Coster had been blocked from any representation on the board and from meaningful access to UIP’s financial records. She filed for a custodian under Delaware’s Section 226 — the statutory remedy for deadlocked companies.
The board’s response was to sell a one-third equity interest to Jim Bonnell, a long-time UIP employee to whom equity had apparently long been promised. The board retained an independent financial advisor — McLean — to value the company, and the stock was sold at the appraised price. The transaction diluted both Coster and Schwat from 50% to one-third each, broke the deadlock (Schwat and Bonnell would now outvote Coster), and mooted the custodian action.
Coster sued to cancel the stock sale, arguing it was designed to interfere with her voting rights and block her statutory remedy.

Why Entire Fairness Wasn’t the End of the Analysis

At trial, Chancellor McCormick applied the entire fairness standard — Delaware’s most exacting level of review — because two of the three board members were interested in the transaction. She found the process “by no means optimal” but concluded that the independent McLean valuation made the price fair. Having found the transaction entirely fair, she dismissed Coster’s claims.

The Supreme Court, in a 2021 en banc opinion authored by Chief Justice Seitz, reversed. The core holding: fiduciary conduct in Delaware is “twice-tested” — first for legal authorization (which entire fairness addresses), and second for equity. Passing the entire fairness test meant the stock sale was legally authorized. But because the transaction diluted Coster’s voting rights and mooted her statutory custodian remedy, additional equitable review was required under the Schnell/Blasius line of cases.

Put simply: you can pay a fair price for stock and still act inequitably if the purpose of issuing that stock is to entrench the board or disenfranchise a shareholder. The valuation doesn’t cure the motive.

The New Framework: Unocal with Teeth

On the second appeal in 2023, the Supreme Court did something practitioners should pay close attention to: it folded the Blasius “compelling justification” test into Unocal’s proportionality framework. When a board takes action that has a disenfranchising effect on stockholders, the court now applies Unocal with heightened sensitivity to protect the stockholder vote.

The two-part test, as articulated in Coster, asks: Did the board face a threat to an important corporate interest or to the achievement of a significant corporate benefit? And was the board’s response reasonable and proportionate to that threat, with the minimum possible impairment of stockholder rights?

In UIP’s case, the board ultimately survived this scrutiny on remand — and the reason is more specific than most commentary suggests. The Chancery Court found that appointing a custodian with broad managerial powers would likely trigger termination or default provisions in UIP’s essential special purpose entity contracts, threatening to destroy the company’s core revenue streams. That wasn’t a generic deadlock concern — it was an existential operational risk, and it provided the concrete justification the enhanced standard demanded. Bonnell’s long-standing equity promise reinforced the board’s case. But the Supreme Court’s framework makes clear that future boards will have to meet this standard, and a valuation alone won’t get them there.

What This Means for Valuations in Deadlock Situations

This is where the case hits closest to home for valuation practitioners. In the original trial, the McLean valuation did exactly what a valuation is supposed to do: an independent advisor applied accepted methodology and produced a defensible number. The Chancery Court found it credible and relied on it for the fair price determination. None of that was disturbed on appeal.

But the Supreme Court’s ruling reframes how that valuation fits into the legal analysis. A credible valuation is a prerequisite for fair price. It is not, however, a shield against equitable claims when the transaction’s purpose is to alter the balance of power among shareholders. The valuation answers the question “what is the stock worth?” It does not answer the question “should this stock be issued at all?”

For counsel advising a board in a deadlocked or closely held company, this creates a sequencing issue. The instinct is to start with the valuation — get the number right and the transaction will survive scrutiny. After Coster, the valuation is the second step, not the first. The first step is establishing that the board has a legitimate corporate purpose for the transaction that doesn’t depend on disenfranchising any shareholder, and that the transaction is the least restrictive means of achieving that purpose. The valuation supports the “fair price” prong; the board’s deliberations, documented in real time, support the equitable prong.

The Practical Checklist for Boards

If you’re advising a board that’s considering a stock issuance or other transaction that will shift voting power in a closely held company, Coster provides a clear framework. Before reaching for a valuation, make sure the board can answer these questions:

What is the corporate purpose? The board needs an affirmative business reason for the transaction that exists independent of the voting consequences. In Coster, the long-standing promise of equity to a key employee, combined with the risk that a court-appointed custodian would trigger default provisions in UIP’s SPE contracts and destroy the company’s revenue base, provided that justification. “We need to break the deadlock” is weaker standing alone — it comes dangerously close to “we need to outvote the other shareholder.” The board needs to identify the specific operational harm the deadlock is causing or will cause.

Were alternatives considered? The board should document that it considered less dilutive alternatives. Could the deadlock be resolved through mediation, a buyout offer, or a negotiated governance change? If the stock issuance was the first and only option considered, that looks like a board working backward from a desired outcome. In Coster, the courts weighed heavily that Schwat had offered Coster buyout terms based on independent valuations before resorting to the stock sale, and that Coster had demanded a buyout at roughly 30 times UIP’s equity value — a demand the court viewed as unreasonable. That documented history of good-faith alternatives was essential to surviving enhanced scrutiny.

Is the disenfranchisement proportionate? Even with a legitimate purpose, the means must be proportionate to the threat. Issuing enough stock to break a deadlock is different from issuing enough stock to render the minority shareholder irrelevant. The quantum of dilution matters.

Is the price independently determined? This is where the valuation comes in — but it comes in last, not first. Once the board has documented its corporate purpose, considered alternatives, and calibrated the scope of the issuance, an independent valuation ensures the price is fair. Without the preceding steps, the valuation is window dressing on a transaction that may be inequitable regardless of price.

When You Don’t Need a Separate Valuation Engagement

Not every deadlocked company needs a formal valuation to resolve the impasse. If both shareholders are willing to negotiate a buyout, a mutually agreed-upon appraiser or a formula price in the shareholders’ agreement (if one exists) may be sufficient. If the company is pursuing a custodian appointment under Section 226, the custodian will handle the process. A separate valuation engagement makes sense when the board is considering a unilateral transaction — a stock issuance, a dilutive capital raise, a forced buyback — that will change the balance of power without the other shareholder’s consent. In that scenario, the valuation is essential for the fair price prong, but as Coster demonstrates, it’s only one piece of a larger puzzle.

The Real Lesson

Coster v. UIP is not primarily a valuation case. It’s a corporate governance case that happens to involve a valuation. The McLean valuation did its job — it produced a credible number, and the court found the price fair. What the valuation couldn’t do was justify the decision to issue stock for the purpose of diluting a 50% shareholder’s voting rights. After Coster, a fair price is necessary but not sufficient. The board’s purpose, its deliberative process, the alternatives it considered, and the proportionality of its response all matter independently of the number on the valuation report. For lawyers advising boards in closely held companies, this means the governance analysis comes first and the valuation engagement comes second.

If you’re working through a deadlock or a contested transaction in a closely held company and need an independent valuation to support the fair price analysis, happy to talk through what’s needed. Sometimes a scoping conversation is enough to tell you whether a full engagement is warranted.

get in touch

Let's talk.

Schedule a free consultation meeting to discuss your valuation needs. 

Table of Contents

Related Posts

Schedule a Meeting